Species differences in dopamine transporters: Postmortem changes and glycosylation differences

Amrat Patel, George Uhl, Michael J. Kuhar

Research output: Contribution to journalArticle

Abstract

The apparent molecular masses of photoaffinity-labeled dopamine transporters (DATs) from rat, human, dog, and primate kidney COS cells expressing the rat DAT1 cDNA differ. Sequences predicted from cDNA cloning reveal only one amino acid difference between the length of the rat and human DAT but one less site for potential N-linked glycosylation in the human DAT. Possible posttranslational and postmortem bases for species differences in DAT molecular mass were explored. Rat DAT proteins from striata subjected to ∼5 h of postmortem delay modeled after the human postmortem delay process revealed small but consistent losses in apparent molecular mass and in cocaine analogue binding; the DAT molecular mass displayed no further losses for up to 30 h of model postmortem treatment. Degradative postmortem changes could thus contribute to molecular mass differences between rat and human DATs. Neuraminidase treatment reduced the apparent molecular mass of native rat DAT but not that of the rat DAT expressed in COS cells, suggesting that the sugars added to the DAT expressed in COS cells were different than those added to the rat brain striatal transporter. These differences could account for the somewhat higher Km values for expressed DAT cDNA in COS cells when compared with the wildtype striatal transporter. These results are in accord with the differences in number of predicted N-linked glycosylation sites between rat and human DATs and with cell-type specificity in transporter posttranslational processing.

Original languageEnglish (US)
Pages (from-to)496-500
Number of pages5
JournalJournal of Neurochemistry
Volume61
Issue number2
StatePublished - Aug 1993

Fingerprint

Postmortem Changes
Glycosylation
Dopamine Plasma Membrane Transport Proteins
Rats
Molecular mass
COS Cells
Corpus Striatum
Complementary DNA
Cloning
Neuraminidase
Cocaine
Sugars
Primates

Keywords

  • Dopamine
  • Glycosylation
  • Photoaffinity
  • Postmortem delay
  • Species
  • Transporter

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Species differences in dopamine transporters : Postmortem changes and glycosylation differences. / Patel, Amrat; Uhl, George; Kuhar, Michael J.

In: Journal of Neurochemistry, Vol. 61, No. 2, 08.1993, p. 496-500.

Research output: Contribution to journalArticle

Patel, Amrat ; Uhl, George ; Kuhar, Michael J. / Species differences in dopamine transporters : Postmortem changes and glycosylation differences. In: Journal of Neurochemistry. 1993 ; Vol. 61, No. 2. pp. 496-500.
@article{f73697054b564f7d923380051f648565,
title = "Species differences in dopamine transporters: Postmortem changes and glycosylation differences",
abstract = "The apparent molecular masses of photoaffinity-labeled dopamine transporters (DATs) from rat, human, dog, and primate kidney COS cells expressing the rat DAT1 cDNA differ. Sequences predicted from cDNA cloning reveal only one amino acid difference between the length of the rat and human DAT but one less site for potential N-linked glycosylation in the human DAT. Possible posttranslational and postmortem bases for species differences in DAT molecular mass were explored. Rat DAT proteins from striata subjected to ∼5 h of postmortem delay modeled after the human postmortem delay process revealed small but consistent losses in apparent molecular mass and in cocaine analogue binding; the DAT molecular mass displayed no further losses for up to 30 h of model postmortem treatment. Degradative postmortem changes could thus contribute to molecular mass differences between rat and human DATs. Neuraminidase treatment reduced the apparent molecular mass of native rat DAT but not that of the rat DAT expressed in COS cells, suggesting that the sugars added to the DAT expressed in COS cells were different than those added to the rat brain striatal transporter. These differences could account for the somewhat higher Km values for expressed DAT cDNA in COS cells when compared with the wildtype striatal transporter. These results are in accord with the differences in number of predicted N-linked glycosylation sites between rat and human DATs and with cell-type specificity in transporter posttranslational processing.",
keywords = "Dopamine, Glycosylation, Photoaffinity, Postmortem delay, Species, Transporter",
author = "Amrat Patel and George Uhl and Kuhar, {Michael J.}",
year = "1993",
month = "8",
language = "English (US)",
volume = "61",
pages = "496--500",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Species differences in dopamine transporters

T2 - Postmortem changes and glycosylation differences

AU - Patel, Amrat

AU - Uhl, George

AU - Kuhar, Michael J.

PY - 1993/8

Y1 - 1993/8

N2 - The apparent molecular masses of photoaffinity-labeled dopamine transporters (DATs) from rat, human, dog, and primate kidney COS cells expressing the rat DAT1 cDNA differ. Sequences predicted from cDNA cloning reveal only one amino acid difference between the length of the rat and human DAT but one less site for potential N-linked glycosylation in the human DAT. Possible posttranslational and postmortem bases for species differences in DAT molecular mass were explored. Rat DAT proteins from striata subjected to ∼5 h of postmortem delay modeled after the human postmortem delay process revealed small but consistent losses in apparent molecular mass and in cocaine analogue binding; the DAT molecular mass displayed no further losses for up to 30 h of model postmortem treatment. Degradative postmortem changes could thus contribute to molecular mass differences between rat and human DATs. Neuraminidase treatment reduced the apparent molecular mass of native rat DAT but not that of the rat DAT expressed in COS cells, suggesting that the sugars added to the DAT expressed in COS cells were different than those added to the rat brain striatal transporter. These differences could account for the somewhat higher Km values for expressed DAT cDNA in COS cells when compared with the wildtype striatal transporter. These results are in accord with the differences in number of predicted N-linked glycosylation sites between rat and human DATs and with cell-type specificity in transporter posttranslational processing.

AB - The apparent molecular masses of photoaffinity-labeled dopamine transporters (DATs) from rat, human, dog, and primate kidney COS cells expressing the rat DAT1 cDNA differ. Sequences predicted from cDNA cloning reveal only one amino acid difference between the length of the rat and human DAT but one less site for potential N-linked glycosylation in the human DAT. Possible posttranslational and postmortem bases for species differences in DAT molecular mass were explored. Rat DAT proteins from striata subjected to ∼5 h of postmortem delay modeled after the human postmortem delay process revealed small but consistent losses in apparent molecular mass and in cocaine analogue binding; the DAT molecular mass displayed no further losses for up to 30 h of model postmortem treatment. Degradative postmortem changes could thus contribute to molecular mass differences between rat and human DATs. Neuraminidase treatment reduced the apparent molecular mass of native rat DAT but not that of the rat DAT expressed in COS cells, suggesting that the sugars added to the DAT expressed in COS cells were different than those added to the rat brain striatal transporter. These differences could account for the somewhat higher Km values for expressed DAT cDNA in COS cells when compared with the wildtype striatal transporter. These results are in accord with the differences in number of predicted N-linked glycosylation sites between rat and human DATs and with cell-type specificity in transporter posttranslational processing.

KW - Dopamine

KW - Glycosylation

KW - Photoaffinity

KW - Postmortem delay

KW - Species

KW - Transporter

UR - http://www.scopus.com/inward/record.url?scp=0027291899&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027291899&partnerID=8YFLogxK

M3 - Article

C2 - 8336137

AN - SCOPUS:0027291899

VL - 61

SP - 496

EP - 500

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 2

ER -